Table 3 Detection rates for preeclampsia < 37, ≥ 37 weeks of gestation, and for all preeclampsia for 5% and 10% false-positive rates based on maternal characteristics and platelet parameters at 16–19 gestational weeks (n = 9346)
| Â | Preterm PE | Term PE | Total PE | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | AUC | p-value | Detection rate (95%) | AUC | p-value | Detection rate (95%) | AUC | p-value | Detection rate (95%) | |||
| Â | FPR 5% | FPR 10% | FPR 5% | FPR 10% | FPR 5% | FPR 10% | ||||||
Base model | 0.775 |  | 22.9 (8.6–37.1) | 45.7 (28.6–62.9) | 0.674 |  | 17.9 (10.5–27.4) | 34.7 (25.3–44.2) | 0.694 |  | 19.2 (12.3–27.7) | 37.7 (29.2–46.2) |
Plus | ||||||||||||
 PC | 0.786 | 0.332 | 20.0 (8.6–34.3) | 40.0 (22.9–57.1) | 0.683 | 0.184 | 17.9 (10.5–26.3) | 36.8 (27.4–46.3) | 0.706 | 0.018 | 21.5 (13.9–29.2) | 35.4 (26.9–43.9) |
 MPV | 0.807 | 0.158 | 34.3 (17.1–51.4) | 48.6 (31.4–65.7) | 0.677 | 0.639 | 21.1 (12.6–31.6) | 34.7 (25.3–45.3) | 0.700 | 0.445 | 21.5 (14.6–29.2) | 38.5 (30.6–47.7) |
 PCT | 0.821 | 0.066 | 25.7 (11.4–40.0) | 42.9 (25.7–60.0) | 0.679 | 0.366 | 19.0 (11.6–27.4) | 34.7 (26.3–45.3) | 0.711 | 0.041 | 21.4 (13.9–29.2) | 33.9 (26.2–43.1) |
 PDW | 0.772 | 0.704 | 22.9 (11.4–37.1) | 42.9 (28.6–60.0) | 0.687 | 0.168 | 22.1 (12.6–31.6) | 34.7 (25.3–44.2) | 0.696 | 0.539 | 20.8 (13.9–27.7) | 36.2 (27.7–43.9) |
 PC + MPV + PCT + PDW | 0.849 | 0.015 | 31.4 (17.1–48.6) | 48.6 (31.4–65.7) | 0.701 | 0.021 | 23.2 (14.7–32.6) | 34.7 (25.3–45.3) | 0.717 | 0.015 | 22.3 (14.6–30.0) | 38.5 (29.2–46.9) |